Terms: = Bone cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292
195 results:
1. Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.
Oporto Espuelas M; Burridge S; Kirkwood AA; Bonney D; Watts K; Shenton G; Jalowiec KA; O'Reilly MA; Roddie C; Castleton A; Clesham K; Nicholson E; Alajangi R; Prabhu S; George L; Uttenthal B; Gabelli M; Neill L; Besley C; Chaganti S; Wynn RF; Bartram J; Chiesa R; Lucchini G; Pavasovic V; Rao A; Rao K; Silva J; Samarasinghe S; Vora A; Clark P; Cummins M; Marks DI; Amrolia P; Hough R; Ghorashian S
Blood Cancer J; 2024 Apr; 14(1):66. PubMed ID: 38622139
[TBL] [Abstract] [Full Text] [Related]
2. GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of bmpr1a.
Yang Y; Ding M; Yin H; Chen W; Shen H; Diao W; Yang L; Qin H; Gan W; Qiu X; Guo H
Int J Biol Sci; 2024; 20(4):1297-1313. PubMed ID: 38385080
[TBL] [Abstract] [Full Text] [Related]
3. Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate cancer.
Saylor PJ; Otani K; Balza R; Ukleja J; Pleskow H; Fisher R; Kusaka E; Otani YS; Badusi PO; Smith MR; Meneely E; Olivier K; Lowe AC; Toner M; Maheswaran S; Haber DA; Yeap BY; Lee RJ; Miyamoto DT
JCO Precis Oncol; 2024 Feb; 8():e2300230. PubMed ID: 38354328
[TBL] [Abstract] [Full Text] [Related]
4. Stromal BMP signaling regulates mucin production in the large intestine via interleukin-1/17.
Wang Y; Lou R; Zhang Z; Xiao C; Yu S; Wei S; Liu Y; Fu W; Li B; Chen YG
Sci Adv; 2023 Oct; 9(43):eadi1827. PubMed ID: 37889976
[TBL] [Abstract] [Full Text] [Related]
5. METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway.
Liu R; Yin G; Tuo H; Guo Y; Zhu Y; Zhang L; Yang W; Liu Q; Wang Y
Biol Direct; 2023 Sep; 18(1):53. PubMed ID: 37658413
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of a new technique using artificial intelligence for quantification of plasma cells on CD138 immunohistochemistry.
Gantana EJ; Nell EM; Musekwa E; Lohlun RK; Chetty C; Moodley K; Chabunya S; Ras J; Chapanduka ZC
Int J Lab Hematol; 2024 Feb; 46(1):50-57. PubMed ID: 37621174
[TBL] [Abstract] [Full Text] [Related]
7. Bioinformatics Analysis of the Genetic and Epigenetic Alterations of bone Morphogenetic Protein Receptors in Metastatic Breast cancer.
Hermawan A; Putri H
Biochem Genet; 2024 Apr; 62(2):594-620. PubMed ID: 37486509
[TBL] [Abstract] [Full Text] [Related]
8. bone Morphogenetic Protein 13 Has Protumorigenic Effects on Hepatocellular Carcinoma Cells In Vitro.
Kersten V; Seitz T; Sommer J; Thasler WE; Bosserhoff A; Hellerbrand C
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446238
[TBL] [Abstract] [Full Text] [Related]
9. bone metastatic cancer of unknown primary at initial presentation.
Matsuoka M; Onodera T; Yokota I; Iwasaki K; Suzuki Y; Masanari H; Kondo E; Iwasaki N
Clin Transl Oncol; 2024 Feb; 26(2):461-467. PubMed ID: 37395989
[TBL] [Abstract] [Full Text] [Related]
10. Whole genome sequencing and disease pattern in patients with juvenile polyposis syndrome: a nationwide study.
Jelsig AM; van Overeem Hansen T; Gede LB; Qvist N; Christensen LL; Lautrup CK; Ljungmann K; Christensen LT; Rønlund K; Tørring PM; Bertelsen B; Sunde L; Karstensen JG
Fam Cancer; 2023 Oct; 22(4):429-436. PubMed ID: 37354305
[TBL] [Abstract] [Full Text] [Related]
11. Assessment of Frailty Index at 66 Years of Age and Association With Age-Related Diseases, Disability, and Death Over 10 Years in Korea.
Jang J; Jung H; Shin J; Kim DH
JAMA Netw Open; 2023 Mar; 6(3):e2248995. PubMed ID: 36862415
[TBL] [Abstract] [Full Text] [Related]
12. FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells.
Quist-Løkken I; Andersson-Rusch C; Kastnes MH; Kolos JM; Jatzlau J; Hella H; Olsen OE; Sundan A; Knaus P; Hausch F; Holien T
Cell Commun Signal; 2023 Jan; 21(1):25. PubMed ID: 36717825
[TBL] [Abstract] [Full Text] [Related]
13. Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial.
Meduri B; Baldissera A; Iotti C; Scheijmans LJEE; Stam MR; Parisi S; Boersma LJ; Ammendolia I; Koiter E; Valli M; Scandolaro L; Busz D; Stenfert Kroese MC; Ciabatti S; Giacobazzi P; Ruggieri MP; Engelen A; Munafò T; Westenberg AH; Verhoeven K; Vicini R; D'Amico R; Lohr F; Bertoni F; Poortmans P; Frezza GP
J Clin Oncol; 2023 Apr; 41(12):2201-2210. PubMed ID: 36623246
[TBL] [Abstract] [Full Text] [Related]
14. Individualized combination therapies based on whole-exome sequencing displayed significant clinical benefits in a glioblastoma patient with secondary osteosarcoma: case report and genetic characterization.
Yi GZ; Zhu TC; Que TS; Li ZY; Huang GL
BMC Neurol; 2022 Oct; 22(1):390. PubMed ID: 36271359
[TBL] [Abstract] [Full Text] [Related]
15. Clinical risk factors for severity and prognosis of antiresorptive agent-related osteonecrosis of the jaw: a retrospective observational study.
Nashi M; Hirai T; Iwamoto T; Takenobu T
J Bone Miner Metab; 2022 Nov; 40(6):1014-1020. PubMed ID: 36166107
[TBL] [Abstract] [Full Text] [Related]
16. Adenomatous Polyposis Phenotype in bmpr1a and SMAD4 Variant Carriers.
Rosner G; Petel-Galil Y; Laish I; Levi Z; Kariv R; Strul H; Gilad O; Gluck N
Clin Transl Gastroenterol; 2022 Oct; 13(10):e00527. PubMed ID: 36049049
[TBL] [Abstract] [Full Text] [Related]
17. Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating bmpr1a lysosomal degradation.
Jiang B; Zhao X; Chen W; Diao W; Ding M; Qin H; Li B; Cao W; Chen W; Fu Y; He K; Gao J; Chen M; Lin T; Deng Y; Yan C; Guo H
Nat Commun; 2022 Jul; 13(1):4141. PubMed ID: 35842443
[TBL] [Abstract] [Full Text] [Related]
18. Application of Endoprosthetic Replacement in Old Patients with Isolated Proximal Femoral bone Metastases.
Liu P; Wang Z; Zhang S; Ding G; Tan K; Zhou J
Ann Surg Oncol; 2022 Dec; 29(13):8623-8630. PubMed ID: 35606471
[TBL] [Abstract] [Full Text] [Related]
19. bone Marrow Surveillance of Pediatric cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia.
Spitzer B; Rutherford KD; Gundem G; McGovern EM; Millard NE; Arango Ossa JE; Cheung IY; Gao T; Levine MF; Zhang Y; Medina-Martínez JS; Feng Y; Ptashkin RN; Bolton KL; Farnoud N; Zhou Y; Patel MA; Asimomitis G; Cobbs CC; Mohibullah N; Huberman KH; Arcilla ME; Kushner BH; Modak S; Kung AL; Zehir A; Levine RL; Armstrong SA; Cheung NKV; Papaemmanuil E
Clin Cancer Res; 2022 Apr; 28(8):1614-1627. PubMed ID: 35078859
[TBL] [Abstract] [Full Text] [Related]
20. Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT.
Czerw T; Iacobelli S; Malpassuti V; Koster L; Kröger N; Robin M; Maertens J; Chevallier P; Watz E; Poiré X; Snowden JA; Kuball J; Kinsella F; Blaise D; Reményi P; Mear JB; Cammenga J; Rubio MT; Maury S; Daguindau E; Finnegan D; Hayden P; Hernández-Boluda JC; McLornan D; Yakoub-Agha I
Bone Marrow Transplant; 2022 Feb; 57(2):261-270. PubMed ID: 34853433
[TBL] [Abstract] [Full Text] [Related]
[Next]
